Ischemic heart disease — all decisions

The Board remands the claims for service connection for various disabilities and an increased rating for skin cancer to correct duty-to-assist errors.

The Board remands the issues for further development and readjudication by the AOJ.

The Board granted service connection for multiple disabilities, including thoracolumbar spine disability, bilateral knee and hip disabilities, heart disease, erectile dysfunction, COPD, and denied an initial rating higher than 50 percent for MDD with GAD.

The Board granted an effective date of February 26, 2013, for coronary artery disease with valvular heart disease and March 31, 2017, for diabetes mellitus type 2 with erectile dysfunction.

The Board granted service connection for bilateral hearing loss, tinnitus, and OSA but denied service connection for hypertension, hypertensive heart disease, right hip pain (secondary to knee disabilities), left ankle disability, and right ankle disability.

The Board remands the claim for further development to verify the Veteran's in-service exposure to herbicide agents, including his participation in Top Secret missions.

The Board denied service connection for coronary artery disease, finding it less likely than not that the condition was related to the Veteran's service or exposure to contaminated water at Camp Lejeune.

The Board remands the claims for service connection for ischemic heart disease/cardiovascular disease, diabetes, and high blood pressure as further medical evidence is needed.

The Board granted service connection for hypertension, coronary artery disease, congestive heart failure with ICD placement, diabetes mellitus, gastroesophageal reflux disease, tinnitus, sinus tachycardia, and cardiomyopathy. The claims for irritable bowel syndrome and an acquired psychiatric disorder were remanded.

The appeals for service connection for chronic kidney disease, diabetes mellitus (DM), hypertension (HTN), hypothyroidism, and ischemic heart disease are dismissed due to the death of the Veteran.

The Board denied service connection for hypertension, ischemic heart disease, sinusitis, and neuropathy of the bilateral upper and lower extremities as they arose during a period of service determined to be under conditions other than honorable. The Board also remanded the issue of entitlement to service connection for bilateral hearing loss.

The Board remands the claims for service connection for coronary artery disease and diabetes mellitus to correct a pre-decisional duty to assist error related to obtaining community care records.

The Board granted service connection for bilateral hearing loss, ischemic heart disease (IHD), percutaneous coronary intervention (PCI) with stent placement as secondary to IHD, hypertensive heart disease, and emphysema. The COPD claim was denied.

The veteran's appeal for service connection for generalized anxiety disorder, major depressive disorder, PTSD, coronary artery disease, and hypertension was dismissed as it was not timely filed.

The Board denied an initial compensable disability rating for hypothyroidism but granted an earlier effective date of January 26, 2022, for the award of service connection for hypothyroidism. The Board also remanded a claim for service connection for valvular heart disease.

The motion to vacate the Board's 2021 decision denying service connection for ischemic heart disease with atrial fibrillation was dismissed due to the Veteran's death.

The Board denied the Veteran's claims for earlier effective dates for the awards of service connection and increased ratings, finding that no evidence supports an earlier date than April 1, 2024.

The Board denied a rating higher than 60 percent for heart disease and a rating higher than 40 percent for bilateral hearing loss, but restored the 60 percent rating for gout effective June 1, 2020. The claims for ratings higher than 30 percent for right shoulder disability were remanded.

The Board denied service connection for a back disability, heart disease, and colon cancer as the evidence did not establish that these conditions were related to the Veteran's active military service.

The Board granted a 100 percent evaluation for the Veteran's coronary artery disease based on a workload of three or fewer metabolic equivalents (METs) resulting in symptoms of heart failure.